Cargando…
Protocol for a randomised controlled trial to study cryoprevention of chemotherapy-induced oral mucositis after autologous stem cell transplantation
INTRODUCTION: A majority of patients who receive myeloablative therapy prior to hematopoetic stem cell transplantation develop oral mucositis (OM). This adverse cytotoxic effect manifests as oral mucosal erythema and ulcerations and frequently necessitates high doses of morphine for pain alleviation...
Autores principales: | Walladbegi, Java, Svanberg, Anncarin, Gellerstedt, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224728/ https://www.ncbi.nlm.nih.gov/pubmed/30361399 http://dx.doi.org/10.1136/bmjopen-2018-021993 |
Ejemplares similares
-
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
por: Walladbegi, Java, et al.
Publicado: (2021) -
Correction: Protocol for a randomised controlled trial to study cryoprevention of chemotherapy-induced oral mucositis after autologous stem cell transplantation
Publicado: (2019) -
Can cryoprevention of oral mucositis be obtained at a higher temperature?
por: Mahdi, A., et al.
Publicado: (2021) -
Cryopreventive temperatures prior to chemotherapy
por: Ibrahim, A., et al.
Publicado: (2023) -
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
por: Walladbegi, Java, et al.
Publicado: (2017)